HighlightsThis is the first study to explore the psychometric properties of the OASIS and ODSIS, screening tools for anxiety and mood disorders, in a Spanish sample of patients diagnosed with emotional disorders in a specialized mental health setting. The OASIS and ODSIS are easily administered screening tools with an excellent internal consistency, favorable convergent and discriminant validity, and good sensitivity to therapeutic change. A cut-off point of 10 for both instruments results in the best rate of correct clinical/nonclinical classifications. The Spanish adaptations of the OASIS and the ODSIS demonstrated their cross-cultural utility. The OASIS and ODSIS should make screening of anxiety and depressive symptoms in public health settings more feasible and could facilitate adequate referrals and routine evaluation. AbstractBackground: Anxiety and depressive disorders are the most frequent disorders for which patients seek care in public health settings in Spain. This study aimed at validating the Overall Anxiety Severity and Impairment Scale (OASIS) and the Overall Depression Severity and Impairment Scale (ODSIS), which are brief screening scales for anxiety and depression consisting of only five items each.Methods: The study was conducted in a Spanish clinical sample receiving outpatient mental health treatment (N = 339). A subsample of participants (n = 219) was assessed before and after receiving a course of cognitivebehavioral treatment.Results: The results revealed excellent internal consistency estimates (Cronbach's alpha for the OASIS and the ODSIS was .87 and .94, respectively), along with promising convergent and discriminant validity and testcriterion relationships (i.e., moderate correlation with other measures of depression and anxiety, as well as with neuroticism, quality of life, adjustment, and negative affect). A one-dimensional structure was obtained for the OASIS and the ODSIS. The ROC analyses indicated an area under the curve of .83 for the OASIS and the ODSIS when predicting moderate-to-severe anxiety and depression, respectively. Good sensitivity to therapeutic change was also evidence and the analysis of the sensitivity as a function of 1-specificity area suggested a cutoff value of 10 for both scales.Limitations: Inter-rater reliability of diagnoses with the ADIS-IV interview could not be investigated and the results obtained may not be generalizable to other samples and health settings.Conclusions: The availability of these two short and psychometrically sound measures should make screening of anxiety and depressive symptoms in routine care more feasible.

The use of Information and Communication Technologies (web pages and apps) in mental health has boosted. However, it is unknown which of these two devices can be better in terms of feasibility and acceptability. Our aim is to compare the feasibility, usability, and user satisfaction of two devices (web vs mobile application) of an online program for perinatal depression screening called HappyMom. In total, 348 and 175 perinatal women registered into HappyMom web and app version, respectively. The assessment protocol included different biopsychosocial evaluations (twice during pregnancy and thrice in the postpartum) and a satisfaction questionnaire. Results showed that a higher percentage of women in the web sample (27.3-51.1%) responded to each assessment compared to the app sample (9.1-53.1%). A smaller proportion of women in web sample never responded to any assessments. By contrast, the percentage of women who responded to all assessments was higher in app sample (longitudinal retention sample was 4.6% of web users and 9.1% of app users). In general, high satisfaction was found in both web and app users. Our result showed that online assessment methods are feasible and acceptable by perinatal women. However, dropout rates are a real problem that urge a solution that will be discussed further in the paper. Web and App devices present different advantages and limitations. The choice of one of them must be made taking into account the study's objective, the sample characteristics, and the dissemination possibilities.

Recent studies have shown that women are more likely than men to use the Internet to seek health information and that the use of technology is common among perinatal women. Access to the Internet is growing through the global use of mobile phones and apps, in both developed and less developed countries. This pattern is particularly relevant for clinicians and researchers who are interested in the use of technologies to disseminate perinatal depression interventions. In a cross-sectional anonymous online survey for English and Spanish-speaking perinatal women, 509 pregnant (77.6 percent) and postpartum (22.4 percent) women provided demographic and Information and Communication Technologies data. Results indicated that the single device with greatest access was the mobile phone (47.5 percent). The majority of the sample had Internet access through mobile phones, computers, or both. Significant differences in socioeconomic status were found for Internet seeking behavior of health-related information and downloading apps between those with and without Internet access. Ninety percent of respondents (n = 267) searched for health-related information and 72.3 percent had downloaded any kind of app. More than half of respondents (57 percent, n = 188) downloaded a health-related app and 26.9 percent reported having paid for the apps. This study shows preliminary evidence to suggest the need to design, develop, and test apps that aim to disseminate prevention programs for perinatal depression.

The present work is a new contribution about the short-and longterm efficacy of virtual reality (VR) exposure therapy for the treatment of flying phobia (FP). We present data from pre-treatment, posttreatment and 1-year follow-up assessments in a sample of nine participants using a multiple baseline design. The treatment programme included a main therapeutic component: VR exposure (six sessions), accompanied by one session of education about anxiety, flying and exposure. The VR software developed by our team is described. Our software included, besides the virtual scenario used by most researchers, the plane, two new scenarios: the room and the airport, developed to work with the patients anticipatory anxiety. The results obtained, at post-treatment and 1 year after the completion of the treatment, support the efficacy of VR in the treatment of flying phobia. VR produced an activation of the fear and avoidance structures and a progressive decrement of fear, avoidance and belief in catastrophic thoughts. The scores in other specific self-report meaures of flying phobia confirm these findings. After the treatment, all participants flew. Our data support the efficacy of VR for the treatment of flying phobia achieved by other studies. Our contribution to this field is the use of VR exposure as the only therapeutic component, the long-term efficacy data, and the use of VR software for the treatment of anticipatory anxiety.